Retartutide 20mg

1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. Its unique mechanism of action has generated significant interest within the scientific research community for studies involving metabolic regulation, energy balance, and endocrine function.

Retatrutide is widely studied in laboratory settings focused on glucose metabolism, appetite signalling, body weight regulation, and broader metabolic pathways. The peptide's multi-receptor activity makes it a valuable compound for exploring complex interactions involved in metabolic health and physiological regulation.

Manufactured to high purity standards, Retatrutide is supplied exclusively for laboratory research and analytical applications.

For research use only. Not intended for human or animal consumption, therapeutic use, veterinary use, diagnostic purposes, or any form of clinical application.